OTC

Strength

2; 30 mg/5mL; mg/5mL

NDC

68047012016

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

8/21/2024

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

9/15/2003

Pharmacological Classes

Adrenergic alpha-Agonists
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+17.9%

5Y

+17.9%

All

+33.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.